This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Woo, E. S. Articles by Lazo, J. S. Search for Related Content PubMed PubMed Citation Articles by Woo, E. S. Articles by Lazo, J. S.

Nucleocytoplasmic Functionality of Metallothionein¹

Department of Pharmacology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania 15261

Appropriate nucleocytoplasmic partitioning of proteins can direct diverse cellular processes. Metallothioneins (MTs) are thiol-rich, stress-inducible proteins that can afford protection against oxidants, mutagens, and anticancer drugs. MTs display discrete nucleocytoplasmic sequestration patterns despite their small size (M_r 6,000). We demonstrate subcellular location-specific functionality of MT using a regulated expression system that restricts MT expression to the nucleus or the cytoplasm in MT-null fibroblasts. Specifically, we found that cytoplasmic but not nuclear expression of MT decreases the level of intracellular reactive oxygen species and is more cytoprotective against the prototypic oxidizing agent tert-butyl hydroperoxide. Cytoplasmic MT expression also protects against the cytotoxicity of the heavy metal CdCl₂, whereas nuclear expression protects against the cytotoxicity of the mutagenic agent N-methyl-N'-nitro-N-nitrosoguanidine. These data support the hypothesis that essential cytotoxic targets of both oxidants and heavy metals reside in the cytoplasm and establish the importance of nucleocytoplasmic partitioning for the function of small protective proteins such as MTs.

¹ Supported by NIH Grants CA61299 (to J. S. L.), CA62781 (to E. S. W.), and American Cancer Society Grant IRG-58-35 (to E. S. W.).

² To whom requests for reprints should be addressed, at Department of Pharmacology, E1340 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261. Phone: (412) 648-9319; Fax: (412) 648-2229; E-mail: lazo@pop.pitt.edu.

Received 3/28/97. Accepted 7/30/97.

This article has been cited by other articles:

				P. J. Smith, M. Wiltshire, E. Furon, J. H. Beattie, and R. J. Errington Impact of overexpression of metallothionein-1 on cell cycle progression and zinc toxicity Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1399 - C1408. [Abstract] [Full Text] [PDF]

				M. Levadoux, C. Mahon, J. H. Beattie, H. M. Wallace, and J. E. Hesketh Nuclear Import of Metallothionein Requires Its mRNA to Be Associated with the Perinuclear Cytoskeleton J. Biol. Chem., December 3, 1999; 274(49): 34961 - 34966. [Abstract] [Full Text] [PDF]

				M. Penkowa, J. Carrasco, M. Giralt, T. Moos, and J. Hidalgo CNS Wound Healing Is Severely Depressed in Metallothionein I- and II-Deficient Mice J. Neurosci., April 1, 1999; 19(7): 2535 - 2545. [Abstract] [Full Text] [PDF]